Substance P

<strong>Substance P</strong> <strong>Catalog number:</strong> MDP0347 <strong>CAS Number: </strong>16960-16-0 <strong>Sequence: </strong>Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Gly-Leu-Met-NH2 . 3AcOH . 5H2O <strong>Amount:</strong> 5 mg <strong>Molecular Weight:</strong> 1347.6 g/mol <strong>Supplied as:</strong> Powder <strong>Applications:</strong> molecular tool for various biochemical applications <strong>Storage:</strong> -20 °C <strong>WARNING:</strong> For in vitro Research Use Only. NOT for use on humans or animals. <strong>Grade:</strong> Biotechnology grade. All products are highly pure. <strong>References:</strong> 1: Mashaghi A, Marmalidou A, Tehrani M, Grace PM, Pothoulakis C, Dana R. Neuropeptide substance P and the immune response Cell Mol Life Sci. 2016 Nov;73(22):4249-4264. 2: Redkiewicz P. The Regenerative Potential of Substance P Int J Mol Sci. 2022 Jan 11;23(2):750. 3: Feickert M, Burckhardt BB. Substance P in cardiovascular diseases - A bioanalytical review Clin Chim Acta. 2019 Aug;495:501-506. 4: Pernow B. Substance P Pharmacol Rev. 1983 Jun;35(2):85-141. 5: Sandberg BE, Iversen LL. Substance P J Med Chem. 1982 Sep;25(9):1009-15. 6: Mroz EA, Leeman SE. Substance P Vitam Horm. 1977;35:209-81. 7: Leeman SE, Mroz EA. Substance P Life Sci. 1974 Dec 15;15(12):2033-44. 8: Mistrova E, Kruzliak P, Chottova Dvorakova M. Role of substance P in the cardiovascular system Neuropeptides. 2016 Aug;58:41-51. 9: Bernstein JE, Hamill JR. Substance P J Invest Dermatol. 1981 Aug;77(2):250-1. <a href="https://pubmed.ncbi.nlm.nih.gov/17618972">10: Donkin JJ, Turner RJ, Hassan I, Vink R. Substance P in traumatic brain injury Prog Brain Res. 2007;161:97-109. </a> <br><strong>Products Related to Substance P can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>